Inhibitor of protein kinase CK2 (NHTP23)
Home > PRODUCTS > Biochemicals > All Inhibitors

Diversity screening library discount

Newsletter Subscription

Stay updated with our new products and services. You can unsubscribe at any time.

Inhibitor of protein kinase CK2 (NHTP23)

3-(5-p-Tolyl-thieno[2,3-d]pyrimidin-4-ylamino)-benzoic acid

inhibitor of protein kinase CK2, IC50 = 0.01 Î¼M

NHTP23, inhibitor of protein kinase CK2

OTAVAchemicals Catalogue Number: 7013050095

CAS Registry Number: 683798-89-2

Purity: 90%+


Ref.: Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines. Ostrynska OV, Balanda AO, Bdzhola VG, Golub AG, Kotey IM, Kukharenko OP, Gryshchenko AA, Briukhovetska NV, Yarmoluk SM. Eur J Med Chem. 2016, 115: 148-160.


Abstract: An extension of our previous research work has resulted in a number of new ATP-competitive CK2 inhibitors that have been identified among 4-aminothieno[2,3-d]pyrimidine derivatives. The most active compounds obtained in the course of the research are 3-(5-p-tolyl-thieno[2,3-d]pyrimidin-4-ylamino)-benzoic acid, 5e (NHTP23, IC50 = 0.01 uM), 3-(5-phenyl-thieno[2,3-d]pyrimidin-4-ylamino)-benzoic acid, 5g (NHTP25, IC50 = 0.065 uM) and 3-(6-methyl-5-phenyl-thieno[2,3-d]pyrimidin-4-ylamino)-benzoic acid, 5n (NHTP33, IC50 = 0.008 uM). Structure-activity relationships of the tested 4-aminothieno[2,3-d]pyrimidine derivatives have been studied and their binding mode with ATP-acceptor site of CK2 has been proposed. A negative effect of intramolecular hydrogen bonding in the compounds' structure is discussed.

DOI: 10.1016/j.ejmech.2016.03.004


Price info:
1 MG 35 EUR
5 MG 85 EUR
10 MG 120 EUR
300uL of 10mM solution

45 EUR